ImmunoOncology

Melanoma First Line Therapy 2021

Adjuvant and Neoadjuvant Therapy for Melanoma Weber 2021

Metastatic Melanoma - Doublet vs Triplet therapy

Role of Circulating Tumor Cells/DNA & Liquid Biopsy in Melanoma - David Polsky

Adjuvant therapy for Melanoma - Amaria

Immunotherapy for Metastatic Disease with PD-1

Cut it Out, Melanoma and Surgical Care: Genevieve Boland MD, PhD

Hitting the Mark with Targeted Therapy: BRAF, NRAS, CKIT, etc...Sullivan

Microbiome, T cells, Adoptive Therapy - Mark Faries MD discusses

Survivorship in Melanoma - Jennifer Drew LCWS

Novel Therapies for Metastatic Melanoma - Omid Hamid MD

Adjuvant Treatment for Melanoma Dr. Alexandra Gangi

Precision Medicine - Chioces Through Your Pathology Report

Surgery in Melanoma - Mark Faries MD, The Angeles Clinic and Research Institute

TIL and Adoptive Therapy - Mark B Faries MD

Oncolytic Immunotherapy - Robert H Andtbacka

New Checkpoint Inhibitors & Immunotherapy in Metastatic Melanoma - Michael Postow MD

Immuno-Oncology, Immune Therapy, PD-1 in Melanoma - Omid Hamid MD

Survivorship in Melanoma - Brianna Hoffner MSN AOCNP

Targeted Therapy in Melanoma - Richard D Carvajal MD

Cancer Immunotherapy - PD-1 and PD-L1

Response to Targeted and Immunotherapy through Biopsy- Dr. Wargo Melanoma Education Symposium 2014

Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014

The Development of Therapies in Metastatic Melanoma- Dr. Patel Melanoma Education Symposium 2014

Immunotherapy: T-Cell Adoptive Therapy - Dr. Faries Melanoma Education Symposium 2014

Welcome: Keynote - Dr. Piro Melanoma Education Symposium 2014

Surgical Options for Metastatic Melanoma - Dr. Kirchoff Melanoma Education Symposium 2014

Future Therapies for Melanoma - Dr. Hamid Melanoma Education Symposium 2014

T-cell Adoptive Therapy for Melanoma - Melanoma Education Symposium, Patrick Hwu MD

Surgery for Malignant Melanoma - Melanoma Education Symposium, Mark Faries MD